Neurology

Reports of high-impact neurology studies by medical professionals

Association between maternal body mass index in early pregnancy and incidence of cerebral palsy

1. This retrospective cohort study found that among Swedish women with singleton children, maternal overweight and obesity were significantly associated with incidence of cerebral...

Suboptimal dietary habits linked to deaths from heart disease, stroke, and type 2 diabetes

1. Over 45% of deaths due to heart disease, stroke, and type 2 diabetes in US adults in 2012 was due to suboptimal dietary...

Ischemic stroke from cervical artery dissection associated with history of migraine

1. In this case-control study of ischemic strokes in younger adults, stroke from cervical artery dissection (CEAD) was associated with increased prevalence of history...

Treating subclinical hypothyroidism and hypothyroxinemia in pregnancy does not impact child IQ

1. In pregnant women, treating subclinical hypothyroidism or hypothyroxinemia with levothyroxine did not significantly impact cognitive outcomes in children up to age 5 years of age...

Reminder devices may not improve medication adherence: The REMIND trial

1. In this randomized controlled trial, three low-cost reminder devices (pill bottle strip with toggles, digital timer cap, or standard pillbox) did not significantly...

Late-life mentally stimulating activities may decrease risk of mild cognitive impairment

1. This prospective cohort study showed that mentally stimulating activities (computer use, craft activities, social activities and playing games) in late-age (>70 years old)...

Researchers validate scoring of postconcussive symptom measure to characterize duration 

1. After analyzing multiple approaches to the Postconcussion Symptom Inventory (PCSI), researchers found that an increase in severity on 2 or more PCSI items...

Ocrelizumab decreases multiple sclerosis relapse rate compared to interferon beta-1a

1. Patients with multiple sclerosis (MS) treated with ocrelizumab experienced lower annualized relapse rates compared to those treated with interferon beta-1a over a 96-month...

Ocrelizumab associated with lower progression rates for primary progressive multiple sclerosis: The ORATORIO trial

1. A significant decrease in the rate of clinical and MRI progression was observed for Primary progressive multiple sclerosis (PPMS) patients that received ocrelizumab. 2....

Asymptomatic women at high risk for Multiple Sclerosis may have early subclinical neuroimaging abnormalities

1. Women at higher risk for multiple sclerosis (MS) (based on family history, genetic testing, blood biomarkers, etc.) had significantly more early imaging and...
licensing as small

Popular